Is $CHRS pump-proof?

Coherus Oncology, Inc.: trap-risk read from social crowding, price extension, and SEC disclosure flags. Updated 2026-09-07.

$CHRS
Coherus Oncology, Inc.
CLEAR RISK
33
/ 100 trap score
Price and crowd are quiet right now, but there's dilution machinery on file. Quiet isn't the same as clean; a rally here feeds the share printer.
Hype / crowding
13
Run-up / extension
5
Structural risk
95
$Live ATM program (424B5, 11 days ago): an at-the-market agreement lets the company sell new shares into the market continuously, including right now [424B5 (ATM) 2026-08-28]↗
🔒 3 more filings flagged on $CHRS: see all of them free.
All 4 flags + filing links, free. No spam, unsubscribe anytime.
PumpProof · pumpproof.com
as of 2026-09-07 · not financial advice

The record on $CHRS

first scored Aug 18: +9% since
39Aug 18
30Aug 28
33Aug 30
32Aug 31
33Sep 1
32Sep 2
33Sep 5
33Sep 7
Every score we publish is snapshotted the day it runs. Wins and misses stay on the record. Full ledger in the Friday email.
What these filings mean
What an ATM offering is →What a shelf registration is →How share dilution works →All the filing explainers →
Check any other ticker free at pumpproof.com

Get the Sunday watchlist before Monday's open

Every Sunday evening: the names heating up on weekend chatter before they hit this board, scored against their filings. Plus Friday receipts: how every score aged, wins and misses. Free, in your inbox.